Number of studies, heterogeneity, generalisability, and the choice of method for meta-analysis

J Neurol Sci. 2017 Oct 15:381:347. doi: 10.1016/j.jns.2017.09.026. Epub 2017 Sep 20.

Authors

Ambrish Singh¹, Salman Hussain², Abul Kalam Najmi³

Affiliations

¹ 36-H, Pocket A3, Mayur Vihar Phase-III, New Delhi, India. Electronic address: ambrishagastya@gmail.com.
² (Department of Pharmaceutical Medicine (Division of Pharmacology), School of Pharmaceutical Education and Research, Jamia Hamdard (Hamdard University), New Delhi, India).
³ (Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard (Hamdard University), New Delhi, India).

PMID: 28967410
DOI: 10.1016/j.jns.2017.09.026

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Atrial Fibrillation*
Cerebral Hemorrhage*
Humans
Risk
Stroke

Substances

Anticoagulants